Bryce Palmgren, MD
Orthopaedic Surgery · Manhattan, KSNPI 1518934025
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 64.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $2,198 and has fallen 91.9% since, to $178 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in KS, where the typical reported total is $3,614.
Across 26 payments — averaging $132.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Titan Surgical Group, LLC$751
- Vericel Corporation$322
- Medline Industries LP$49
- Zimmer Biomet$28
- Restor3d, Inc.$26
- plus $47 from 2 others
What the payments were for
- Travel & lodging$90726%
- Food & beverage$51215%
- Education$2,02759%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $2,223 |
| Titan Surgical Group, LLC | 1 | $751 |
| Vericel Corporation | 15 | $322 |
| Medline Industries LP | 1 | $49 |
| Zimmer Biomet | 1 | $28 |
| Restor3d, Inc. | 1 | $26 |
| Stryker | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $23 |
How this compares
$3,446 in reported general payments places this provider in the 45th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 144 | $1,926 |
| Celecoxib | 62 | $1,297 |
| Tramadol Hcl | 179 | $523 |
| Cefadroxil | 53 | $324 |
| Promethazine Hcl | 65 | $173 |
| Methylprednisolone | 23 | $156 |
| Meloxicam | 68 | $138 |
| Cephalexin | 90 | $123 |
| Clindamycin Hcl | 33 | $98 |
| Ciprofloxacin Hcl | 17 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Manhattan
- Nicholas DuethmanManhattan$57K
- Timothy CareyManhattan$38K
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
- Jacob DeisterTopeka$185K
- Harold EllsworthLeawood$154K
- Tyler BronWichita$107K
- William ReedLenexa$106K
- Alexander BaileyOverland Park$99K
- Brent WiseKansas City$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.